Wilbur-Ellis Company Announces New and Improved Seed Treatment Product – STEPUP 2.0

DENVER – July 31, 2020 – Wilbur-Ellis announced today the release of a new and improved seed treatment product, STEPUP 2.0., a seed treatment nutritional that is specifically designed to interact with and respond to the seed by supplementing the protein and amino acids released during the early stages of germination, providing a faster and more uniform emergence, resulting in higher yields. This exclusive seed treatment product features a newly redesigned, higher-concentrated formulation.

Due to this more concentrated formulation, STEPUP 2.0 allows growers to use more products on their seeds, while tapping into the potential for lower use rates without sacrificing performance. Ultimately this gives the grower a more consistent return on investment.

“The redesigned formulation allows for lower use rates on seed which can result in better seed flow at planting while retaining its performance,” said Wilbur-Ellis’ National Seed Treatment Manager Paul Johnson.

Additionally, STEPUP 2.0 has proven results on soybeans through several field trials, as this value-added seed treatment nutritional has averaged an increase of over 2.12 bushels over two years of trials, taking soybean yields and return on investment to the next level.

To learn more about STEPUP 2.0 or find your Wilbur-Ellis Agribusiness representative, visit wilburellisagribusiness.com.

# # #

This press release is intended for informational use only and cannot be used as a replacement for product label. Any products mentioned in this press release may only be sold in states where they are registered or where registration is not a factor. Please contact your local Wilbur-Ellis representative for more information.

About the Wilbur-Ellis Companies   

Founded in 1921, the Wilbur-Ellis companies are leading international marketers and distributors of agricultural products, animal feed and specialty chemicals and ingredients. By developing strong relationships, making strategic market investments and capitalizing on new opportunities, the Wilbur-Ellis companies have continued to grow the business with sales now over $3.3 billion.